RxDoctor Payments Data

Matthew Moretti, DO

Family Medicine · Ft Lauderdale, FLNPI 1841380227

Payments from drug & device makers

$995in general payments, 2019–2025

Across 53 payments — averaging $18.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$281
  • Lilly USA, LLC$132
  • Pfizer$118
  • Viiv Healthcare Company$74
  • GSK$54
  • Amgen$52
  • plus $285 from 11 others

What the payments were for

  • Food & beverage$995100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$995 in reported general payments places this provider in the 60th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$108,643
Medicare patients
406
Services billed
1,062

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide122$130,666
EliquisApixaban98$94,871
JardianceEmpagliflozin42$58,164
MounjaroTirzepatide44$46,919
Trelegy ElliptaFluticasone/Umeclidin/Vilanter50$41,358
XareltoRivaroxaban23$33,618
JanuviaSitagliptin Phosphate18$25,727
TrulicityDulaglutide22$24,622
FarxigaDapagliflozin Propanediol12$20,394
Rosuvastatin Calcium624$7,531
Emtricitabine-Tenofovir DisopEmtricitabine/Tenofovir (Tdf)14$7,190
Atorvastatin Calcium566$5,319
Nifedipine ErNifedipine189$5,110
SynthroidLevothyroxine Sodium52$4,712
Levothyroxine Sodium308$3,755

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$281$130,666122 claims
PfizerEliquis$118$94,87198 claims
Lilly USA, LLCMounjaro, Trulicity$132$71,54166 claims
Boehringer IngelheimJardiance$23$58,16442 claims
GSKTrelegy Ellipta$54$41,35850 claims
Johnson & JohnsonXarelto$25$33,61823 claims
MerckJanuvia$16$25,72718 claims
AstraZenecaFarxiga$20$20,39412 claims
AbbVieSynthroid$47$4,71252 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Ft Lauderdale

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →